bpc 157 inject BPC-157 Therapy in Austin BPC-157 - DrWell

Mounjaro (Tirzepatide) Injection 12.5 mg/0.5 mL Prefilled Syringes are prescription medications used to treat type 2 diabetes. They contain 12.5 mg of tirzepatide, which is a glucagon-like peptide-1 (GLP-1) receptor agonist and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist

Because of the disappointing results of clinical trials, minimizing homocysteine levels is no longer the primary goal of our recommendations

Im not wild about them

Your doctor will need to give you a shot of B12

I love it, my food noise is gone, and it was easy to inject

In April 2026, the FDA removed BPC-157 from its Category 2 list (substances with safety concerns that were previously restricted from compounding)